Copyright Reports & Markets. All rights reserved.

Global and United States Cell Therapy and Acellular Therapy Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cell Therapy and Acellular Therapy Revenue in Cell Therapy and Acellular Therapy Business (2017-2022) & (US$ Million) Introduction
    • 1.2 Global Cell Therapy and Acellular Therapy Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Cell Therapy and Acellular Therapy Market Size for the Year 2017-2028
      • 1.2.2 Global Cell Therapy and Acellular Therapy Market Size for the Year 2017-2028
    • 1.3 Cell Therapy and Acellular Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.3.1 The Market Share of United States Cell Therapy and Acellular Therapy in Global, 2017 VS 2022 VS 2028
      • 1.3.2 The Growth Rate of Cell Therapy and Acellular Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.4 Cell Therapy and Acellular Therapy Market Dynamics
      • 1.4.1 Cell Therapy and Acellular Therapy Industry Trends
      • 1.4.2 Cell Therapy and Acellular Therapy Market Drivers
      • 1.4.3 Cell Therapy and Acellular Therapy Market Challenges
      • 1.4.4 Cell Therapy and Acellular Therapy Market Restraints
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Cell Therapy and Acellular Therapy by Type

    • 2.1 Cell Therapy and Acellular Therapy Market Segment by Type
      • 2.1.1 Cell Therapy
      • 2.1.2 Acellular Therapy
    • 2.2 Global Cell Therapy and Acellular Therapy Market Size by Type (2017, 2022 & 2028)
    • 2.3 Global Cell Therapy and Acellular Therapy Market Size by Type (2017-2028)
    • 2.4 United States Cell Therapy and Acellular Therapy Market Size by Type (2017, 2022 & 2028)
    • 2.5 United States Cell Therapy and Acellular Therapy Market Size by Type (2017-2028)

    3 Cell Therapy and Acellular Therapy by Application

    • 3.1 Cell Therapy and Acellular Therapy Market Segment by Application
      • 3.1.1 Cardiology
      • 3.1.2 Hepatology
      • 3.1.3 Neurology
      • 3.1.4 Gastroenterology
      • 3.1.5 Oncology
    • 3.2 Global Cell Therapy and Acellular Therapy Market Size by Application (2017, 2022 & 2028)
    • 3.3 Global Cell Therapy and Acellular Therapy Market Size by Application (2017-2028)
    • 3.4 United States Cell Therapy and Acellular Therapy Market Size by Application (2017, 2022 & 2028)
    • 3.5 United States Cell Therapy and Acellular Therapy Market Size by Application (2017-2028)

    4 Global Cell Therapy and Acellular Therapy Competitor Landscape by Company

    • 4.1 Global Cell Therapy and Acellular Therapy Market Size by Company
      • 4.1.1 Top Global Cell Therapy and Acellular Therapy Companies Ranked by Revenue (2021)
      • 4.1.2 Global Cell Therapy and Acellular Therapy Revenue by Player (2017-2022)
    • 4.2 Global Cell Therapy and Acellular Therapy Concentration Ratio (CR)
      • 4.2.1 Cell Therapy and Acellular Therapy Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Companies of Cell Therapy and Acellular Therapy in 2021
      • 4.2.3 Global Cell Therapy and Acellular Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Cell Therapy and Acellular Therapy Headquarters, Revenue in Cell Therapy and Acellular Therapy Business (2017-2022) & (US$ Million) Type
      • 4.3.1 Global Cell Therapy and Acellular Therapy Headquarters and Area Served
      • 4.3.2 Global Cell Therapy and Acellular Therapy Companies Revenue in Cell Therapy and Acellular Therapy Business (2017-2022) & (US$ Million) Type
      • 4.3.3 Date of International Companies Enter into Cell Therapy and Acellular Therapy Market
    • 4.4 Companies Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Cell Therapy and Acellular Therapy Market Size by Company
      • 4.5.1 Top Cell Therapy and Acellular Therapy Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Cell Therapy and Acellular Therapy Revenue by Players (2020, 2021 & 2022)

    5 Global Cell Therapy and Acellular Therapy Market Size by Region

    • 5.1 Global Cell Therapy and Acellular Therapy Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Cell Therapy and Acellular Therapy Market Size by Region (2017-2028)
      • 5.2.1 Global Cell Therapy and Acellular Therapy Market Size by Region: 2017-2022
      • 5.2.2 Global Cell Therapy and Acellular Therapy Market Size by Region (2023-2028)

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Cell Therapy and Acellular Therapy Market Size YoY Growth 2017-2028
      • 6.1.2 North America Cell Therapy and Acellular Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Cell Therapy and Acellular Therapy Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Cell Therapy and Acellular Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Cell Therapy and Acellular Therapy Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Cell Therapy and Acellular Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Cell Therapy and Acellular Therapy Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Cell Therapy and Acellular Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Cell Therapy and Acellular Therapy Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Cell Therapy and Acellular Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Aegle Therapeutics Corp
      • 7.1.1 Aegle Therapeutics Corp Company Details
      • 7.1.2 Aegle Therapeutics Corp Business Overview
      • 7.1.3 Aegle Therapeutics Corp Cell Therapy and Acellular Therapy Introduction
      • 7.1.4 Aegle Therapeutics Corp Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.1.5 Aegle Therapeutics Corp Recent Development
    • 7.2 ArunA Biomedical
      • 7.2.1 ArunA Biomedical Company Details
      • 7.2.2 ArunA Biomedical Business Overview
      • 7.2.3 ArunA Biomedical Cell Therapy and Acellular Therapy Introduction
      • 7.2.4 ArunA Biomedical Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.2.5 ArunA Biomedical Recent Development
    • 7.3 Capricor Therapeutics, Inc.
      • 7.3.1 Capricor Therapeutics, Inc. Company Details
      • 7.3.2 Capricor Therapeutics, Inc. Business Overview
      • 7.3.3 Capricor Therapeutics, Inc. Cell Therapy and Acellular Therapy Introduction
      • 7.3.4 Capricor Therapeutics, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.3.5 Capricor Therapeutics, Inc. Recent Development
    • 7.4 Codiak BioSciences, Inc.
      • 7.4.1 Codiak BioSciences, Inc. Company Details
      • 7.4.2 Codiak BioSciences, Inc. Business Overview
      • 7.4.3 Codiak BioSciences, Inc. Cell Therapy and Acellular Therapy Introduction
      • 7.4.4 Codiak BioSciences, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.4.5 Codiak BioSciences, Inc. Recent Development
    • 7.5 Direct Biologics, LLC
      • 7.5.1 Direct Biologics, LLC Company Details
      • 7.5.2 Direct Biologics, LLC Business Overview
      • 7.5.3 Direct Biologics, LLC Cell Therapy and Acellular Therapy Introduction
      • 7.5.4 Direct Biologics, LLC Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.5.5 Direct Biologics, LLC Recent Development
    • 7.6 EV Therapeutics, Inc.
      • 7.6.1 EV Therapeutics, Inc. Company Details
      • 7.6.2 EV Therapeutics, Inc. Business Overview
      • 7.6.3 EV Therapeutics, Inc. Cell Therapy and Acellular Therapy Introduction
      • 7.6.4 EV Therapeutics, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.6.5 EV Therapeutics, Inc. Recent Development
    • 7.7 Evox Therapeutics Ltd
      • 7.7.1 Evox Therapeutics Ltd Company Details
      • 7.7.2 Evox Therapeutics Ltd Business Overview
      • 7.7.3 Evox Therapeutics Ltd Cell Therapy and Acellular Therapy Introduction
      • 7.7.4 Evox Therapeutics Ltd Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.7.5 Evox Therapeutics Ltd Recent Development
    • 7.8 Exogenus Therapeutics
      • 7.8.1 Exogenus Therapeutics Company Details
      • 7.8.2 Exogenus Therapeutics Business Overview
      • 7.8.3 Exogenus Therapeutics Cell Therapy and Acellular Therapy Introduction
      • 7.8.4 Exogenus Therapeutics Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.8.5 Exogenus Therapeutics Recent Development
    • 7.9 Invitrx Therapeutics, Inc.
      • 7.9.1 Invitrx Therapeutics, Inc. Company Details
      • 7.9.2 Invitrx Therapeutics, Inc. Business Overview
      • 7.9.3 Invitrx Therapeutics, Inc. Cell Therapy and Acellular Therapy Introduction
      • 7.9.4 Invitrx Therapeutics, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.9.5 Invitrx Therapeutics, Inc. Recent Development
    • 7.10 Organicell Regenerative Medicine, Inc.
      • 7.10.1 Organicell Regenerative Medicine, Inc. Company Details
      • 7.10.2 Organicell Regenerative Medicine, Inc. Business Overview
      • 7.10.3 Organicell Regenerative Medicine, Inc. Cell Therapy and Acellular Therapy Introduction
      • 7.10.4 Organicell Regenerative Medicine, Inc. Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.10.5 Organicell Regenerative Medicine, Inc. Recent Development
    • 7.11 Rion LLC
      • 7.11.1 Rion LLC Company Details
      • 7.11.2 Rion LLC Business Overview
      • 7.11.3 Rion LLC Cell Therapy and Acellular Therapy Introduction
      • 7.11.4 Rion LLC Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.11.5 Rion LLC Recent Development
    • 7.12 Stem Cell Medicine Ltd.
      • 7.12.1 Stem Cell Medicine Ltd. Company Details
      • 7.12.2 Stem Cell Medicine Ltd. Business Overview
      • 7.12.3 Stem Cell Medicine Ltd. Cell Therapy and Acellular Therapy Introduction
      • 7.12.4 Stem Cell Medicine Ltd. Revenue in Cell Therapy and Acellular Therapy Business (2017-2022)
      • 7.12.5 Stem Cell Medicine Ltd. Recent Development

    8 Research Findings and Conclusion

      9 Appendix

      • 9.1 Research Methodology
        • 9.1.1 Methodology/Research Approach
        • 9.1.2 Data Source
      • 9.2 Author Details

      Summary:

      Market Analysis and Insights: Global and United States Cell Therapy and Acellular Therapy Market
      This report focuses on global and United States Cell Therapy and Acellular Therapy market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Cell Therapy and Acellular Therapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Cell Therapy accounting for % of the Cell Therapy and Acellular Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Cardiology was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Cell Therapy and Acellular Therapy market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Cell Therapy and Acellular Therapy Scope and Market Size
      Cell Therapy and Acellular Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cell Therapy and Acellular Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Cell Therapy and Acellular Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Cell Therapy and Acellular Therapy market is segmented into
      Cell Therapy
      Acellular Therapy
      Segment by Application, the Cell Therapy and Acellular Therapy market is segmented into
      Cardiology
      Hepatology
      Neurology
      Gastroenterology
      Oncology
      Regional and Country-level Analysis
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Cell Therapy and Acellular Therapy Market Share Analysis
      Cell Therapy and Acellular Therapy market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Cell Therapy and Acellular Therapy business, the date to enter into the Cell Therapy and Acellular Therapy market, Revenue in Cell Therapy and Acellular Therapy Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
      The major vendors covered:
      Aegle Therapeutics Corp
      ArunA Biomedical
      Capricor Therapeutics, Inc.
      Codiak BioSciences, Inc.
      Direct Biologics, LLC
      EV Therapeutics, Inc.
      Evox Therapeutics Ltd
      Exogenus Therapeutics
      Invitrx Therapeutics, Inc.
      Organicell Regenerative Medicine, Inc.
      Rion LLC
      Stem Cell Medicine Ltd.
      Buy now